ATE554104T1 - Domänen der konstanten region von immunoglobulinen mit verbesserter stabilität - Google Patents

Domänen der konstanten region von immunoglobulinen mit verbesserter stabilität

Info

Publication number
ATE554104T1
ATE554104T1 AT07755812T AT07755812T ATE554104T1 AT E554104 T1 ATE554104 T1 AT E554104T1 AT 07755812 T AT07755812 T AT 07755812T AT 07755812 T AT07755812 T AT 07755812T AT E554104 T1 ATE554104 T1 AT E554104T1
Authority
AT
Austria
Prior art keywords
sub
polypeptide
immunoglobulin
pro
region domain
Prior art date
Application number
AT07755812T
Other languages
English (en)
Inventor
Masazumi Matsumura
Jaby Jacob
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE554104T1 publication Critical patent/ATE554104T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT07755812T 2006-04-21 2007-04-20 Domänen der konstanten region von immunoglobulinen mit verbesserter stabilität ATE554104T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79420206P 2006-04-21 2006-04-21
US86077406P 2006-11-21 2006-11-21
PCT/US2007/009693 WO2007124077A2 (en) 2006-04-21 2007-04-20 Immunoglobulin constant region domains with enhanced stability

Publications (1)

Publication Number Publication Date
ATE554104T1 true ATE554104T1 (de) 2012-05-15

Family

ID=38625624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07755812T ATE554104T1 (de) 2006-04-21 2007-04-20 Domänen der konstanten region von immunoglobulinen mit verbesserter stabilität

Country Status (6)

Country Link
EP (1) EP2027154B1 (de)
AT (1) ATE554104T1 (de)
AU (1) AU2007240727B2 (de)
CA (1) CA2649709A1 (de)
ES (1) ES2387023T3 (de)
WO (1) WO2007124077A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011013455A (es) * 2009-07-08 2012-02-13 Amgen Inc Diseño de moleculas de fc de anticuerpo estables y libres de agregacion a traves del diseño de la interfase del dominio de ch3.
EP3586860A1 (de) * 2018-06-22 2020-01-01 Universität Ulm Komplement-inhibitoren und verwendungen davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US6277375B1 (en) * 1997-03-03 2001-08-21 Board Of Regents, The University Of Texas System Immunoglobulin-like domains with increased half-lives
EP1597372A2 (de) * 2003-02-18 2005-11-23 Syngeta Participations AG Expression von e. coli enterotoxine spezifische antikörper in pflanzen

Also Published As

Publication number Publication date
EP2027154A2 (de) 2009-02-25
WO2007124077A2 (en) 2007-11-01
EP2027154B1 (de) 2012-04-18
CA2649709A1 (en) 2007-11-01
AU2007240727A1 (en) 2007-11-01
ES2387023T3 (es) 2012-09-11
WO2007124077A3 (en) 2008-08-07
AU2007240727B2 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
Madsen et al. Design and engineering of bispecific antibodies: insights and practical considerations
IL299221A (en) Cd3 binding antibodies
IL273424B2 (en) Novel bispecific cd3/cd19 polypeptide complexes
FI3402821T3 (fi) PSMA-sitova vasta-aine ja sen käyttöjä
RU2011145038A (ru) Несущие аматоксины мишень-связывающие молекулы для лечения рака
IL273918B1 (en) Trispecific proteins and methods of use
EA200970515A1 (ru) МОДИФИЦИРОВАННЫЕ РАСТВОРИМЫЕ СЛИТЫЕ КОНСТРУКЦИИ РЕЦЕПТОРА FGF И Fc С УЛУЧШЕННОЙ БИОЛОГИЧЕСКОЙ АКТИВНОСТЬЮ
RU2531523C3 (ru) Стабильные и растворимые антитела, ингибирующие vegf
HRP20240415T1 (hr) Kimerni antigenski receptori antigena kapa mijeloma i njihova upotreba
WO2006052591A3 (en) Anti-properdin antibodies, and methods for making and using same
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
ATE420660T1 (de) Antikörper gegen parath-hormon (pth) und ihre verwendungen
RU2015111708A (ru) Способ получения и отбора молекул, включающих по меньшей мере две различные группировки и их применение
IL273196B2 (en) Claudin6 antibodies and methods of treating cancer
NZ585622A (en) Hepatitis c virus antibodies
DE602005022928D1 (de) Antikörper gegen gpnmb und ihre verwendungen
PE20090239A1 (es) ANTAGONISTAS CRIg
MX2023009022A (es) Anticuerpos multiespecificos con especificidad para ror1 y cd3.
RU2018137419A (ru) Связывающиеся с cd38 и pd-l1 молекулы
Omidfar et al. Studies of thermostability in Camelus bactrianus (Bactrian camel) single‐domain antibody specific for the mutant epidermal‐growth‐factor receptor expressed by Pichia
JP2014529590A5 (de)
ZA202310070B (en) Multifunctional bispecific fusion polypeptide
AR129169A2 (es) Materiales y métodos para la unión de lectina tipo ig de unión a ácido siálico
Natsume et al. Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene–Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region
ATE554104T1 (de) Domänen der konstanten region von immunoglobulinen mit verbesserter stabilität